Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 563,000 | 672,000 | 613,000 | 502,000 | 464,000 |
| Receivables | 759,000 | 679,000 | 947,000 | 959,000 | 858,000 |
| Inventories | 1,536,000 | 1,569,000 | 1,547,000 | 1,558,000 | 1,550,000 |
| Other current assets | 1,000 | 1,000 | 22,000 | 23,000 | 0 |
| TOTAL | $2,928,000 | $3,001,000 | $3,207,000 | $3,100,000 | $2,933,000 |
| Non-Current Assets | |||||
| PPE Net | 3,040,000 | 3,078,000 | 3,090,000 | 3,121,000 | 3,131,000 |
| Investments And Advances | 166,000 | 160,000 | 180,000 | 177,000 | 164,000 |
| Intangibles | 48,000 | 48,000 | 48,000 | 48,000 | 48,000 |
| Other Non-Current Assets | 1,085,000 | 1,095,000 | 1,045,000 | 1,042,000 | 1,118,000 |
| TOTAL | $4,339,000 | $4,381,000 | $4,363,000 | $4,388,000 | $4,461,000 |
| Total Assets | $7,267,000 | $7,382,000 | $7,570,000 | $7,488,000 | $7,394,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 37,000 | 42,000 | 52,000 | 38,000 | 43,000 |
| Accounts payable and accrued liabilities | 891,000 | 954,000 | 1,035,000 | 1,023,000 | 1,006,000 |
| Other current liabilities | 219,000 | 184,000 | 204,000 | 181,000 | 223,000 |
| TOTAL | $1,609,000 | $1,686,000 | $1,880,000 | $1,850,000 | $1,673,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,100,000 | 4,099,000 | 4,098,000 | 4,102,000 | 4,064,000 |
| Other Non-Current Liabilities | 1,302,000 | 1,309,000 | 1,274,000 | 1,273,000 | 1,049,000 |
| TOTAL | $5,442,000 | $5,445,000 | $5,390,000 | $5,399,000 | $5,141,000 |
| Total Liabilities | $7,051,000 | $7,131,000 | $7,270,000 | $7,249,000 | $6,814,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 150,378 | 150,085 | 149,892 | 149,698 | 149,674 |
| Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Retained earnings | 1,178,000 | 1,220,000 | 1,312,000 | 1,265,000 | 1,659,000 |
| Other shareholders' equity | -243,000 | -243,000 | -282,000 | -291,000 | -337,000 |
| TOTAL | $216,000 | $251,000 | $300,000 | $239,000 | $580,000 |
| Total Liabilities And Equity | $7,267,000 | $7,382,000 | $7,570,000 | $7,488,000 | $7,394,000 |